NL-OMON23752
Not yet recruiting
Not Applicable
Systemic damage and quality of life in patients with ANCA-associated vasculitis
orthwest Clinics0 sites70 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- ANCA-associated vasculitis, granulomatosis with polyangiits (GPA), microscopic polyangiitis (MPA), Cardiovascular disease, quality of life, depression.
- Sponsor
- orthwest Clinics
- Enrollment
- 70
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •In order to participate in this study, a subject must meet all of the following criteria:
- •Diagnosis GPA or MPA in accordance with the Chapel Hill Consensus Conference guidelines
Exclusion Criteria
- •\- Secondary vasculitis due to rheumatoid arthritis, systemic lupus erythematosus, Sjögren’s syndrome, connective tissue disease
- •\- Drug induced vasculitis
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Systemic damage and quality of life in patients with ANCA-associated vasculitisANCA-associated vasculitisgranulomatosis with polyangitisWegener's disease100279461002914910057166NL-OMON42996oordwest Ziekenhuisgroep140
Not yet recruiting
Not Applicable
Study of Complaints and Quality of life in patient of Cervical cancerHealth Condition 1: C53- Malignant neoplasm of cervix uteriCTRI/2022/02/039893Tata Memorial Hospital
Completed
Not Applicable
Evaluation of the quality of life of patients after anatomical lung resection in NSCLC taking psychosocial factors into consideratioC34F32F43.2Malignant neoplasm of bronchus and lungDepressive episodeAdjustment disordersDRKS00021762Charité Berlin168
Completed
Not Applicable
Investigation of symptoms and quality of life after esophagectomyesophageal cancerJPRN-UMIN000016974Cancer Institute Hospital Ariake100
Not yet recruiting
Not Applicable
Prospective quality of life analysis of patients with metastatic breast cancer during and after radiotherapyC79.9Secondary malignant neoplasm, unspecified siteDRKS00025331niversitätsklinikum Freiburg Klinik für Strahlenheilkunde100